XML 58 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Sep. 30, 2014
Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income $ 18,855 $ 27,655
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 14,580 10,453
Deferred income taxes (1,705) (1,585)
Equity in net (income) loss of equity-method investees (20) (572)
Stock based compensation 2,939 3,237
Tax benefit from stock based compensation (61) (112)
Contingent consideration expense 281 0
Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee 5,334 0
Other non-cash items, net (1,485) 246
Increase (decrease) in cash attributable to changes in operating assets and liabilities, net of amounts applicable to acquisitions:    
Accounts receivable (31,626) 5,966
Inventories (34,427) (12,505)
Other current assets 4,635 (315)
Other assets 661 (717)
Accounts payable and accrued expenses 38,694 17,788
Income taxes (3,495) 3,845
Net cash provided by operating activities 2,614 53,608
CASH FLOWS FROM INVESTING ACTIVITIES    
Proceeds from purchase price settlement for acquisition 0 481
Acquisitions, net of cash acquired (20,310) 0
Purchases of property and equipment (13,260) (12,347)
Proceeds from sale of investment 1,287 0
Net cash used in investing activities (32,283) (11,866)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from exercises of stock options, net of related expenses 1,233 580
Borrowings under bank revolving credit facility 21,500 (13,252)
Repayments of other long-term debt, net (16,521) (1,904)
Excess tax benefits from stock based compensation 1,759 814
Shares withheld for payment of employee payroll taxes (5,744) (3,949)
Net cash provided by financing activities 2,227 (17,711)
Effect of exchange rate changes on cash (3,651) (225)
Net increase (decrease) in cash and cash equivalents (31,093) 23,806
Cash and cash equivalents at beginning of period 123,751 41,263
Cash and cash equivalents at end of period 92,658 65,069
Hain Pure Protein [Member]
   
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee $ 5,334